They enlisted one of their fellows to do a statistical analysis, and published a Sept. 2001 paper in the Journal of the American Medical Association calling for an investigation into potential heart risks caused by Vioxx and Celebrex, a competing drug from Pfizer (nyse: PFE - news - people ).
FORBES: Behind Merck's Fall